Upgrade to SI Premium - Free Trial

Pulse Biosciences, Inc. (PLSE)

25.77 +0.93 (3.74%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Canaccord Starts Pulse Biosciences (PLSE) at Buy June 4, 2026 6:09 AM - StreetInsider Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 May 27, 2026 4:05 PM - BizWire Form 4/A PULSE BIOSCIENCES, INC. For: May 11 Filed by: DUGGAN ROBERT W May 15, 2026 7:26 PM - SEC Filing Form 10-Q PULSE BIOSCIENCES, INC. For: Mar 31 May 14, 2026 9:03 AM - SEC Filing Form SCHEDULE 13D/A PULSE BIOSCIENCES, INC. Filed by: DUGGAN ROBERT W May 13, 2026 6:37 PM - SEC Filing Pulse Biosciences co-chairmen buy $13.3 million in company stock May 12, 2026 7:01 AM - StreetInsider ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million May 12, 2026 7:00 AM - BizWire Form 4/A PULSE BIOSCIENCES, INC. For: May 11 Filed by: LAVIOLETTE PAUL A May 11, 2026 8:53 PM - SEC Filing Form 4 PULSE BIOSCIENCES, INC. For: May 11 Filed by: LAVIOLETTE PAUL A May 11, 2026 6:53 PM - SEC Filing Form 4 PULSE BIOSCIENCES, INC. For: May 11 Filed by: DUGGAN ROBERT W May 11, 2026 6:52 PM - SEC Filing Form DEF 14A PULSE BIOSCIENCES, INC. For: Jun 11 May 11, 2026 9:18 AM - SEC Filing Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference May 8, 2026 7:00 AM - BizWire Form 8-K PULSE BIOSCIENCES, INC. For: May 05 May 6, 2026 9:06 AM - SEC Filing Form 8-K PULSE BIOSCIENCES, INC. For: May 04 May 4, 2026 9:17 AM - SEC Filing Pulse Biosciences, Inc. (PLSE) Tops Q1 EPS by 3c May 4, 2026 7:41 AM - StreetInsider Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results May 4, 2026 7:00 AM - BizWire Form 10-K/A PULSE BIOSCIENCES, INC. For: Dec 31 April 30, 2026 4:16 PM - SEC Filing Form 8-K PULSE BIOSCIENCES, INC. For: Apr 25 April 27, 2026 9:19 AM - SEC Filing Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse Cardiac Catheter System April 27, 2026 5:55 AM - StreetInsider Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026 April 25, 2026 1:00 PM - BizWire Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting April 20, 2026 7:00 AM - BizWire Pulse Biosciences to Host Analyst Event on April 25, 2026 April 17, 2026 7:00 AM - BizWire Form 8-K PULSE BIOSCIENCES, INC. For: Apr 16 April 16, 2026 9:02 AM - SEC Filing Form 8-K PULSE BIOSCIENCES, INC. For: Apr 08 April 9, 2026 9:17 AM - SEC Filing Pulse Biosciences names Liane Teplitsky as COO, expands CMO role April 9, 2026 7:01 AM - StreetInsider Pulse Biosciences Strengthens Executive Leadership Team April 9, 2026 7:00 AM - BizWire Form 8-K PULSE BIOSCIENCES, INC. For: Apr 07 April 7, 2026 12:57 PM - SEC Filing Pulse Biosciences enrolls first patients in pivotal atrial fibrillation study April 7, 2026 7:48 AM - StreetInsider Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation April 7, 2026 7:47 AM - BizWire Form 4 PULSE BIOSCIENCES, INC. For: Mar 23 Filed by: UECKER DARRIN April 3, 2026 5:28 PM - SEC Filing Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference April 2, 2026 4:05 PM - BizWire Form 8-K PULSE BIOSCIENCES, INC. For: Mar 23 March 27, 2026 4:33 PM - SEC Filing Form 8-K PULSE BIOSCIENCES, INC. For: Mar 17 March 17, 2026 8:59 AM - SEC Filing Pulse Biosciences shifts focus to cardiac catheter program after AFib study March 17, 2026 7:02 AM - StreetInsider Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data March 17, 2026 7:00 AM - BizWire Form 8-K PULSE BIOSCIENCES, INC. For: Mar 12 March 12, 2026 9:21 AM - SEC Filing Pulse Biosciences enrolls first patients in thyroid cancer study March 12, 2026 7:01 AM - StreetInsider Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology March 12, 2026 7:00 AM - BizWire Full Article List